Glucose conjugation for the specific targeting and treatment of cancer
Open accessThe DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Cancers of diverse origins exhibit marked glucose avidity and high rates of aerobic glycolysis. Increased understanding of this dysfunctional metabolism known as the Warburg effect has led to an interest in targeting it for cancer therapy. One promising strategy for such targeting is glycoconjugation, the linking of a drug to glucose or another sugar. This review summarizes the most salient examples of glycoconjugates, in which known cytotoxins or targeted anticancer therapeutics have been linked to glucose (or another glucose transporter substrate sugar) for improved cancer targeting and selectivity. Building on these examples, this review also provides a series of guidelines for the design and mechanistic evaluation of future glycoconjugates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 1×
“Today this phenomenon is known as the Warburg effect and is recognized as one of the hallmarks of cancer [3].”
BackgroundWarburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 1×
“Almost a century ago, the German scientist Otto Warburg observed that cancerous tissues consume large amounts of glucose compared to non-transformed tissue and have high rates of aerobic glycolysis [1, 2].”
BackgroundThe metabolism of tumors in the body
Warburg, O., Wind, F., & Negelein, E. (1927) · Journal of General Physiology · doi:10.1085/jgp.8.6.519 · Cited by 4,416 · cited 1×
“Almost a century ago, the German scientist Otto Warburg observed that cancerous tissues consume large amounts of glucose compared to non-transformed tissue and have high rates of aerobic glycolysis [1, 2].”
BackgroundTrastuzumab emtansine for HER2-positive advanced breast cancer
Verma, S., Miles, D., Gianni, L., Krop, I. E., Welslau, M., Baselga, J., Pegram, M., Oh, D.-Y., Diéras, V., Guardino, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1209124 · Cited by 3,834 · cited 1×
“Another antibody-drug conjugate, Kadcyla (trastuzumab emtansine; Figure 2b), received US FDA approval in February 2013 for the treatment of HER2-positive breast cancer following the EMILIA clinical trial [15].”
BackgroundTargeting cancer metabolism: a therapeutic window opens
Vander Heiden, M. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3504 · Cited by 1,411 · cited 1×
“Most efforts have focused on using small molecules to inhibit the function of metabolic enzymes, as comprehensively reviewed elsewhere [10, 11].”
BackgroundParker, N., Turk, M. J., Westrick, E., Lewis, J. D., Low, P. S., & Leamon, C. P. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2004.12.026 · Cited by 1,197 · cited 1×
“For this reason, folate receptor α (FR-α) is overexpressed in an estimated 40% of human cancers (it is expressed only by certain types of epithelial cells in healthy individuals) [17, 18].”
BackgroundDe Vivo, D. C., Trifiletti, R. R., Jacobson, R. I., Ronen, G. M., Behmand, R. A., & Harik, S. I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109053251006 · Cited by 800 · cited 1×
“Incidentally, humans born with a mutated, functionallyimpaired GLUT-1 transporter experience a severe phenotype known as De Vivo disease which results in mental retardation, seizures, and a host of neurological deficits, underscoring the importance of GLUT-1 in supplying glucose to the nervous system [95].”
BackgroundSenter, P. D., & Sievers, E. L. (2012) · Nature Biotechnology · doi:10.1038/nbt.2289 · Cited by 763 · cited 1×
“Adcertis is thought to enter cancer cells via CD30 receptor-mediated endocytosis and subsequently be trafficked to endosomes, where a combination of degradative enzymes and increased acidity lead to cleavage to the active tubulin inhibitor [14].”
BackgroundGenes of glycolysis are ubiquitously overexpressed in 24 cancer classes
Altenberg, B., & Greulich, K. O. (2004) · Genomics · doi:10.1016/j.ygeno.2004.08.010 · Cited by 659 · cited 1×
“Glycolytic enzymes, as well as the insulinindependent glucose transporter GLUT-1, are widely overexpressed in human cancers [4, 5], and high expression levels of these proteins in tumor biopsy samples correlate with poor cancer prognosis, making them attractive therapeutic targets [6–9].”
BackgroundFolate-targeted therapeutic and imaging agents for cancer
Low, P. S., & Kularatne, S. A. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.03.022 · Cited by 585 · cited 1×
“For this reason, folate receptor α (FR-α) is overexpressed in an estimated 40% of human cancers (it is expressed only by certain types of epithelial cells in healthy individuals) [17, 18].”
Background
Cited by
Items 101–200 of 401
In Vitro and In Vivo Efficacy of a Novel Glucose–Methotrexate Conjugate in Targeted Cancer Treatment
Woźniak, M., Pastuch-Gawołek, G., Makuch, S., Wiśniewski, J. Ł., Krenács, T., Hamar, P., Gamian, A., Szeja, W., Szkudlarek, D., Krawczyk, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041748 · Cited by 34
“Since the introduction of glufosfamide [15], the potential of this strategy in diagnosis and therapy has already been realized, yet there is tremendous scope for improvement [7].”
BackgroundA Small Sugar Molecule with Huge Potential in Targeted Cancer Therapy
Pastuch-Gawołek, G., Szreder, J., Domińska, M., Pielok, M., Cichy, P., & Grymel, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030913 · Cited by 39
“A little later, research was continued in Japan and the USA, with promising results [64].”
Blood–brain barrier-crossing dendrimers for glioma theranostics
Wang, J., Wang, Z., Zhang, G., Rodrigues, J., Tomás, H., Shi, X., & Shen, M. (2024) · Biomaterials Science · doi:10.1039/d4bm00043a · Cited by 33
Wu, X., Li, S., Chen, L., Ma, S., Ma, B., Song, L., & Qian, D. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c05485 · Cited by 33
Engineering Targeting Materials for Therapeutic Cancer Vaccines
Briquez, P. S., Hauert, S., de Titta, A., Gray, L. T., Alpar, A. T., Swartz, M. A., & Hubbell, J. A. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00019 · Cited by 32
Computational Modeling of Pharmaceuticals with an Emphasis on Crossing the Blood–Brain Barrier
Alves, P. A., Camargo, L. C., de Souza, G. M., Mortari, M. R., & Homem-de-Mello, M. (2025) · Pharmaceuticals · doi:10.3390/ph18020217 · Cited by 41
“Adjustments to the glycosidic bond orientation or the introduction of specific chemical groups can enhance the permeability and metabolic stability of the prodrugs [104,105].”
Grymel, M., Pastuch-Gawołek, G., Lalik, A., Zawojak, M., Boczek, S., Krawczyk, M., & Erfurt, K. (2020) · Molecules · doi:10.3390/molecules25246019 · Cited by 33
“An increased glycolysi pro ess in cancer cells s assoc ated with overexpression of GLUT ransporters (special transmembra e proteins hat facilita e concentration-dependent glucose uptake inside the cell) [43].”
BackgroundInfluentialZuo, H., Zhang, C., Zhang, Y., & Niu, D. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202309887 · Cited by 33
Mechanisms of cancer cell death induction by triptolide: A comprehensive overview
Feng, K., Li, X., Bai, Y., Zhang, D., & Tian, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24335 · Cited by 36
“These overly expressed GLUTs in cancerous cells are now considered as possible targets for such preferential killing of cancerous cells by cytotoxic agents in conjunction with glucose (NCT01954992) [129].”
BackgroundIdentification of gallic acid based glycoconjugates as a novel tubulin polymerization inhibitors
Upadhyaya, K., Hamidullah, H., Singh, K., Arun, A., Shukla, M. K., Srivastava, N., Ashraf, R., Sharma, A., Mahar, R., Shukla, S. K., et al. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob02113h · Cited by 33
Glycoconjugation: An approach to cancer therapeutics
Molejon, M. I., Weiz, G., Breccia, J. D., & Molejon, M. I. (2020) · World Journal of Clinical Oncology · doi:10.5306/wjco.v11.i3.110 · Cited by 38
Plant constituents: carbohydrates, oils, resins, balsams, and plant hormones
Dilworth, L., Riley, C. K., & Stennett, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18657-8.00021-9 · Cited by 38
A peptide-based pH-sensitive drug delivery system for targeted ablation of cancer cells
Jin, Y., Huang, Y., Yang, H., Liu, G., & Zhao, R. (2015) · Chemical Communications · doi:10.1039/c5cc05184c · Cited by 32
Ibrahim, N., Bonnet, P., Brion, J., Peyrat, J., Bignon, J. S., Levaïque, H., Josselin, B., Robert, T., Colas, P., Bach, S., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112355 · Cited by 33
Glucose-Functionalized Liposomes for Reducing False Positives in Cancer Diagnosis
Tzror-Azankot, C., Betzer, O., Sadan, T., Motiei, M., Rahimipour, S., Atkins, A., Popovtzer, A., & Popovtzer, R. (2020) · ACS Nano · doi:10.1021/acsnano.0c08530 · Cited by 31
Chen, D., Sun, L., Chen, R., Xie, K., Yang, L., & Dai, J. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201600411 · Cited by 29
Granchi, C., Capecchi, A., Frate, G. D., Martinelli, A., Macchia, M., Minutolo, F., & Tuccinardi, T. (2015) · Molecules · doi:10.3390/molecules20058772 · Cited by 29
“Then, we have further functionalized these compounds with sugar portions in order to enhance the uptake by cancer cells, thus exploiting a dual targeting of the Warburg effect [9,10], by following a strategy that was successfully exploited in many other types of antitumor agents [11].”
MethodInfluentialMa, J., Liu, H., Xi, Z., Hou, J., Li, Y., Niu, J., Liu, T., Bi, S., Wang, X., Wang, C., et al. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00386 · Cited by 29
“Based on the previous results regarding the design the glycosylated drugs (Calvaresi and Hergenrother, 2013), we deduced that steric hindrance of hexadecanoic acid blocked the combination of the reported compounds (1-8) with transporters.”
BackgroundResultPotential anti-herpes and cytotoxic action of novel semisynthetic digitoxigenin-derivatives
Boff, L., Munkert, J., Ottoni, F. M., Schneider, N. F. Z., Ramos, G. S., Kreis, W., de Andrade, S. F., Filho, J. D. D. S., Braga, F. C., Alves, R. J., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.01.076 · Cited by 29
Zaritski, A., Castillo‐Ecija, H., Kumarasamy, M., Peled, E., Arzi, R. S., Carcaboso, A. M., & Sosnik, A. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b12682 · Cited by 30
Rodríguez‐Rodríguez, C., Telpoukhovskaia, M. A., Alí‐Torres, J., Rodríguez-Santiago, L., Manso, Y., Bailey, G. A., Hidalgo, J., Sodupe, M., & Orvig, C. (2015) · Metallomics · doi:10.1039/c4mt00167b · Cited by 29
Molecular Tools for Facilitative Carbohydrate Transporters (Gluts)
Tanasova, M., & Fedie, J. R. (2017) · ChemBioChem · doi:10.1002/cbic.201700221 · Cited by 31
Belmonte‐Reche, E., Benassi, A., Peñalver, P., Cucchiarini, A., Guédin, A., Mergny, J., Rosu, F., Gabelica, V., Freccero, M., Doria, F., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114183 · Cited by 27
Barlas, F. B., Celikbas, E., Arslan, M., Timur, S., & Yağcı, Y. (2018) · Journal of Applied Polymer Science · doi:10.1002/app.47250 · Cited by 28
Nayak, D., Rathnanand, M., & Tippavajhala, V. K. (2023) · AAPS PharmSciTech · doi:10.1208/s12249-023-02696-4 · Cited by 27
“Parashar et al . modified bilosomes by coating them with dextrose, a ligand for lectin-specific carbohydrate receptors in spleen and liver cells [92].”
BackgroundWilkins, L. E., Phillips, D. J., Deller, R. C., Davies, G., & Gibson, M. I. (2014) · Carbohydrate Research · doi:10.1016/j.carres.2014.09.009 · Cited by 29
New Conjugates of Quinoxaline as Potent Antitubercular and Antibacterial Agents
Peraman, R., Rajendran, K., Killi, S. K., & Reddy, Y. P. (2016) · International Journal of Medicinal Chemistry · doi:10.1155/2016/6471352 · Cited by 27
An Update on the Recent Advances and Discovery of Novel Tubulin Colchicine Binding Inhibitors
Weng, H., Li, J., Zhu, H., Wong, K. F. C., Zhu, Z., & Xu, J. (2023) · Future Medicinal Chemistry · doi:10.4155/fmc-2022-0212 · Cited by 27
Miranda‐Vera, C., Hernández, Á., García, P. G., Diez, D., García, P. A., & Castro, M. A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15122728 · Cited by 29
Metabolism-Driven High-Throughput Cancer Identification with GLUT5-Specific Molecular Probes
Kannan, S., Begoyan, V., Fedie, J. R., Xia, S., Weseliński, Ł. J., Tanasova, M., & Rao, S. (2018) · Biosensors · doi:10.3390/bios8020039 · Cited by 27
BNCT pancreatic cancer treatment strategy with glucose-conjugated boron drug
Fujimoto, T., Teraishi, F., Kanehira, N., Tajima, T., Sakurai, Y., Kondo, N., Yamagami, M., Kuwada, A., Morihara, A., Kitamatsu, M., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122605 · Cited by 29
Zi, C., Yang, D., Dong, F.-W., Li, G., Li, Y., Ding, Z., Zhou, J., Jiang, Z., & Hu, J. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.02.021 · Cited by 26
Cardullo, N., Spatafora, C., Musso, N., Barresi, V., Condorelli, D. F., & Tringali, C. (2015) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00619 · Cited by 26
A Short and Convenient Synthesis of closo ‐Dodecaborate Sugar Conjugates
Imperio, D., Muz, B., Azab, A. K., Fallarini, S., Lombardi, G., & Panza, L. (2019) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201901412 · Cited by 28
Thermoresponsive microgels containing trehalose as soft matrices for 3D cell culture
Milewska, M., Waśkiewicz, S., Lalik, A., Student, S., Bieg, T., & Wandzik, I. (2016) · Biomaterials Science · doi:10.1039/c6bm00624h · Cited by 27
Krawczyk, M., Pastuch-Gawołek, G., Pluta, A., Erfurt, K., Domiński, A., & Kurcok, P. (2019) · Molecules · doi:10.3390/molecules24224181 · Cited by 26
Agwa, M. M., Marzouk, R. E., & Sabra, S. A. (2024) · RSC Advances · doi:10.1039/d4ra04069d · Cited by 26
Bussolo, V. D., Calvaresi, E. C., Granchi, C., Bino, L. D., Frau, I., Lang, M. C. D., Tuccinardi, T., Macchia, M., Martinelli, A., Hergenrother, P. J., et al. (2015) · RSC Advances · doi:10.1039/c5ra00946d · Cited by 27
Platinum glycoconjugates: “Sweet bullets” for targeted cancer therapy?
Vaidya, S. P., & Patra, M. (2022) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2022.102236 · Cited by 26
Glyco-functionalised quantum dots and their progress in cancer diagnosis and treatment
Ashree, J., Wang, Q., & Chao, Y. (2019) · Frontiers of Chemical Science and Engineering · doi:10.1007/s11705-019-1863-7 · Cited by 23
“Glycoconjugates and carbohydrate derivatives can be effectively used for chemotherapy and also, conjugation of sugars to a known anti-cancer agent can increase the selectivity and hence reduce the toxicity [8].”
BackgroundL-Glucose: Another Path to Cancer Cells
Ono, K., Takigawa, S., & Yamada, K. (2020) · Cancers · doi:10.3390/cancers12040850 · Cited by 28
“As discussed previously, some investigators have thought that GLUTs could be a target of a DDS, providing enhanced glucose uptake in cancerous cells due to GLUT overexpression in these cells [168].”
BackgroundLiu, Z., Liu, D., Zhu, D., & Yu, B. (2023) · Organic Letters · doi:10.1021/acs.orglett.3c01750 · Cited by 24
Tomaszowski, K.-H., Hellmann, N., Ponath, V., Takatsu, H., Shin, H., & Kaina, B. (2017) · Scientific Reports · doi:10.1038/s41598-017-14129-x · Cited by 26
Schwarzenböck, C., Schäffer, A., Pahl, P., Nelson, P. J., Huss, R., & Rieger, B. (2017) · Polymer Chemistry · doi:10.1039/c7py01796k · Cited by 25
Li, M., Yuan, J., Yuan, H., Wu, B.-H., Huang, S., Li, Q., Ou, T., Wang, H., Tan, J., Li, D., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00467 · Cited by 23
Hao, B., Li, R., Wang, P., Wang, Y., Li, X., Xu, P., Zhang, Q., Zhu, X., Zhang, X., & Zhu, Y. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c01845 · Cited by 22
Stereospecific, High-Yielding, and Green Synthesis of β-Glycosyl Esters
Feng, S., & Li, C. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b02534 · Cited by 22
Li, Y., Zhang, Y., Wu, M., Chang, Q., Hu, H., & Zhao, X. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00046 · Cited by 23
Glycoconjugated Metallohelices have Improved Nuclear Delivery and Suppress Tumour Growth In Vivo
Song, H. L., Allison, S. J., Brabec, V., Bridgewater, H. E., Kašpárková, J., Kostrhunová, H., Novohradský, V., Phillips, R. M., Prachařová, J., Rogers, N. J., et al. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202006814 · Cited by 22
Iacopini, D., Vančo, J., Pietro, S. D., Bordoni, V., Zacchini, S., Marchetti, F., Dvořák, Z., Malina, T., Biancalana, L., Trávníček, Z., et al. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105901 · Cited by 22
Salicylketoximes That Target Glucose Transporter 1 Restrict Energy Supply to Lung Cancer Cells
Granchi, C., Qian, Y., Lee, H. Y., Paterni, I., Pasero, C., Iegre, J., Carlson, K. E., Tuccinardi, T., Chen, X., Katzenellenbogen, J. A., et al. (2015) · ChemMedChem · doi:10.1002/cmdc.201500320 · Cited by 24
Lin, C. Y. W. C. H. (2015) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000264 · Cited by 22
“As mentioned earlier, the number of glucose receptors on the cell membrane is in the order of hepatocellular cancer cells > breast cancer cells> prostate cancer cells > normal cells [39].”
BackgroundInfluentialPettenuzzo, N., Brustolin, L., Coltri, E., Gambalunga, A., Chiara, F., Trevisan, A., Biondi, B., Nardon, C., & Fregona, D. (2019) · ChemMedChem · doi:10.1002/cmdc.201900226 · Cited by 22
Hodík, T., Lamač, M., Šťastná, L. Č., Karban, J., Koubková, L., Hrstka, R., Císařová, I., & Pinkas, J. (2014) · Organometallics · doi:10.1021/om500200r · Cited by 24
Zhang, Q., Jin, C., Yu, J., & Lu, W. P. (2018) · ACS Omega · doi:10.1021/acsomega.8b01208 · Cited by 21
Potentiating anti-cancer chemotherapeutics and antimicrobials via sugar-mediated strategies
Mullapudi, S. S., Mitra, D., Li, M., Kang, E. T., Chiong, E., & Neoh, K. G. (2020) · Molecular Systems Design & Engineering · doi:10.1039/c9me00175a · Cited by 22
Influences of different sugar ligands on targeted delivery of liposomes
Zhang, C., Chen, Z., Li, W., Li, L., Tang, S., Jiang, L., Li, M., Peng, H., & Lian, M. (2020) · Journal of drug targeting · doi:10.1080/1061186x.2020.1744156 · Cited by 21
Kanamori, T., Matsuyama, A., 内藤, 秀., Tsuga, Y., Ozako, Y., Ogura, S., Okazaki, S., & Yuasa, H. (2018) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.8b02066 · Cited by 19
Domiński, A., Domińska, M., Skonieczna, M., Pastuch-Gawołek, G., & Kurcok, P. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020290 · Cited by 21
“, by incorporating a sugar unit into the drug structure (glycoconjugation) [26,27] or using pH-sensitive drug carriers [28,29].”
MethodTargeted Delivery and Sustained Antitumor Activity of Triptolide through Glucose Conjugation
He, Q., Minn, I., Wang, Q., Xu, P. H., Head, S. A., Datan, E., Yu, B., Pomper, M. G., & Liu, J. O. (2016) · Angewandte Chemie · doi:10.1002/ange.201606121 · Cited by 20
De Masi, R., & Orlando, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137373 · Cited by 20
“Several cytotoxic agents, including glufosfamide, chlorambucil, busulfan, docetaxel, paclitaxel, have been glycoconjugated to be less toxic to normal cells than parent aglycons [261].”
Background“Sweet tooth”-oriented SN38 prodrug delivery nanoplatform for targeted gastric cancer therapy
Ding, N., Xu, S., Zheng, S., Ye, Q., Xu, L. L., Ling, S., Xie, S., Chen, W., Zhang, Z., Xue, M., et al. (2021) · Journal of Materials Chemistry B · doi:10.1039/d0tb02787a · Cited by 19
Glucose-responsive nanogels efficiently maintain the stability and activity of therapeutic enzymes
Qi, H., Yang, J., Yu, J., Yang, L., Shan, P., Zhu, S., Wang, Y., Li, P., Wang, K., & Zhou, Q. (2022) · Nanotechnology Reviews · doi:10.1515/ntrev-2022-0095 · Cited by 20
“As an example, glucose could be conjugated to nanomedicines realizing the specific targeting and subsequent treatment of cancers [38].”
BackgroundGratal, P. B., Arias, M. S., & Gude, L. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105851 · Cited by 20
Rajeshkumar, R. R., Pavadai, P., Theivendren, P., Deepak, V., Pandian, S. R. K., Kabilan, S. J., Sivakumar, V., Jeyaraman, A., Kumar, A. S. K., Sundar, K., et al. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02480-y · Cited by 22
Glenister, A., Simone, M. I., & Hambley, T. W. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217712 · Cited by 21
Wang, Y., Ma, S., Dai, Z., Rong, Z., & Liu, J. (2019) · Nanoscale · doi:10.1039/c9nr03821c · Cited by 20
Zhang, G., Wang, M., Bobadova‐Parvanova, P., Fronczek, F. R., Smith, K. M., & Vicente, M. G. H. (2022) · Chemistry - A European Journal · doi:10.1002/chem.202200421 · Cited by 18
Domiński, A., Konieczny, T., Godzierz, M., Musioł, M., Janeczek, H., Foryś, A., Domińska, M., Pastuch-Gawołek, G., Piotrowski, T., & Kurcok, P. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112490 · Cited by 19
De, S., & Nag, S. (2023) · Reviews in Inorganic Chemistry · doi:10.1515/revic-2023-0007 · Cited by 19
Glycoconjugates: Advances in modern medicines and human health
Chettri, D., Chirania, M., Boro, D., & Verma, A. K. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122689 · Cited by 21
Theerasilp, M., Chalermpanapun, P., Sunintaboon, P., Sungkarat, W., & Nasongkla, N. (2018) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-018-6177-7 · Cited by 19
Sung, Y., Kerimoğlu, B., Ooi, A., & Tomat, E. (2022) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.2c00250 · Cited by 20
Discovery of Mandelalide E and Determinants of Cytotoxicity for the Mandelalide Series
Nazari, M., Serrill, J., Sikorska, J., Ye, T., Ishmael, J. E., & McPhail, K. L. (2016) · Organic Letters · doi:10.1021/acs.orglett.6b00308 · Cited by 17
Overcoming Hypoxia-Induced Chemoresistance in Cancer Using a Novel Glycoconjugate of Methotrexate
Woźniak, M., Pastuch-Gawołek, G., Makuch, S., Wiśniewski, J. Ł., Ziolkowski, P. P., Szeja, W., Krawczyk, M., & Agrawal, S. (2020) · Pharmaceuticals · doi:10.3390/ph14010013 · Cited by 19
“Therefore, glycoconjugation, in which known cytotoxins or targeted anticancer therapeutics have been linked to glucose to improve cancer targeting and cellular selectivity, has become an appealing strategy for the targeted delivery of anticancer drugs [14,15].”
BackgroundLiu, Y., Huang, J., Wu, M., Bi, L., Lin, Q., Wu, J., Ouyang, Y., Guo, X., Huang, R., Zhang, Y., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114463 · Cited by 17
A Trimodal Closomer Drug‐Delivery System Tailored with Tracing and Targeting Capabilities
Sarma, S. J., Khan, A. A., Goswami, L. N., Jalisatgi, S. S., & Hawthorne, M. F. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201602413 · Cited by 17
Poly(benzofuran-co-arylacetic acid) – a new type of highly functionalized polymers
Nan, A., Bunge, A., Circu, M. V., Petran, A., Hădade, N. D., & Filip, X. (2017) · Polymer Chemistry · doi:10.1039/c7py00523g · Cited by 17
Pettenuzzo, A., Montagner, D., McArdle, P., & Ronconi, L. (2018) · Dalton Transactions · doi:10.1039/c8dt01583j · Cited by 18
Transmembrane Exchange of Fluorosugars: Characterization of Red Cell GLUT1 Kinetics Using 19F NMR
Shishmarev, D., Fontenelle, C. Q., Kuprov, I., Linclau, B., & Kuchel, P. W. (2018) · Biophysical Journal · doi:10.1016/j.bpj.2018.09.030 · Cited by 22
Krawczyk, M., Pastuch-Gawołek, G., Hadasik, A., & Erfurt, K. (2020) · Molecules · doi:10.3390/molecules25184174 · Cited by 16
“The sugar fragment can be used as a drug carrier across the cell membrane by adapting to the structure of the GLUT transporter [6].”
BackgroundDomińska, M., Pastuch-Gawołek, G., Skonieczna, M., Szeja, W., Domiński, A., & Kurcok, P. (2022) · Molecules · doi:10.3390/molecules27206918 · Cited by 18
The role of molecular oxygen in the formation of radiation-engineered multifunctional nanogels
Ditta, L. A., Dahlgren, B., Sabatino, M. A., Dispenza, C., & Jönsson, M. (2019) · European Polymer Journal · doi:10.1016/j.eurpolymj.2019.02.020 · Cited by 16
Yun, C., Li, N., Zhang, Y., Fang, T., Ma, J., Zheng, Z., Zhou, S. H., & Cai, X. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.4c00584 · Cited by 17
Tiwari, G., Mishra, V. K., Kumari, P., Khanna, A., Sharma, S., & Sagar, R. (2024) · RSC Advances · doi:10.1039/d3ra06993a · Cited by 18
Novel glycoconjugated squaraine dyes for selective optical imaging of cancer cells
Shimi, M., Sankar, V., Rahim, M. K. A., Nitha, P. R., Das, S., Radhakrishnan, K. V., & Raghu, K. G. (2017) · Chemical Communications · doi:10.1039/c6cc10282d · Cited by 17
Fadlan, A., Tanimoto, H., Itô, T., Aritomi, Y., Ueno, M., Tokuda, M., Hirohara, S., Obata, M., Morimoto, T., & Kakiuchi, K. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.02.031 · Cited by 15
Bennai, N., Chabrier, A., Fatthalla, M. I., Tran, C., Yen‐Pon, E., Belkadi, M., Alami, M., Grimaud, L., & Messaoudi, S. (2020) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.0c00766 · Cited by 15
Nahrjou, N., Ghosh, A., & Tanasova, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105073 · Cited by 17
Synthesis and Cytotoxic Property of Annonaceous Acetogenin Glycoconjugates
Shi, J., Wu, P., Cheng, X., Wei, X., & Jiang, Z. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s259547 · Cited by 16
Tang, C., Pang, X., Guo, Z., Guo, R., Liu, L., & Chen, X. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.120.000317 · Cited by 14
Ge, Y., Zheng, N., Chen, X., Zhu, J., Sun, W., Olson, J. R., Aga, D. S., Hu, W., Tang, X., & Ren, X. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00097 · Cited by 14
Żurawska, K., Stokowy, M., Kapica, P., Olesiejuk, M., Kudelko, A., Papaj, K., Skonieczna, M., Szeja, W., Walczak, K., & Kasprzycka, A. (2021) · Molecules · doi:10.3390/molecules26237245 · Cited by 13
“Several anticancer drugs such as glufosfamide, paclitaxel, and chlorambucil were conjugated with glucose for improving cancer targeting and selectivity [29].”
BackgroundRecent progress in the synthesis of natural product inspired bioactive glycohybrids
Singh, K., Sharma, S., Tyagi, R., & Sagar, R. (2023) · Carbohydrate Research · doi:10.1016/j.carres.2023.108975 · Cited by 13
Fluorescent Polyvinylphosphonate Bioconjugates for Selective Cellular Delivery
Schwarzenböck, C., Schäffer, A., Nößner, E., Nelson, P. J., Huss, R., & Rieger, B. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201706034 · Cited by 13
Miyazawa, T., Kamiyoshihara, R., Shimizu, N., Harigae, T., Otoki, Y., Ito, J., Kato, S., Miyazawa, T., & Nakagawa, K. (2018) · Royal Society Open Science · doi:10.1098/rsos.171249 · Cited by 11
Multistimuli-responsive magnetic assemblies
BAYKAL, A., Bozkurt, A., Jeremy, R., Asiri, S. M., Lima-Tenório, M. K., Kaewsaneha, C., & Elaïssari, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-08-101995-5.00006-4 · Cited by 16
Synthesis of N-Glycosyl-2-oxindoles by Pd-Catalyzed N-Arylation of 1-Amidosugars
Letribot, B., Redjdal, W., Benmerad, B., Bideau, F. L., Alami, M., & Messaoudi, S. (2020) · Organic Letters · doi:10.1021/acs.orglett.0c01262 · Cited by 13
Role of Glucose Transporters in Drug Membrane Transport
Wang, X., Guo, K., Huang, B., Lin, Z., & Cai, Z. (2020) · Current Drug Metabolism · doi:10.2174/1389200221666200810125924 · Cited by 15
Brustolin, L., Pettenuzzo, N., Nardon, C., Quarta, S., Montagner, I. M., Pontisso, P., Rosato, A., Conte, P., Merigliano, S., & Fregona, D. (2020) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2020.111259 · Cited by 14
Metadata
- Authors
- Calvaresi, E. C., & Hergenrother, P. J.
- Affiliations
- University of Illinois Urbana-Champaign (US)
- Corresponding author
- Hergenrother, Paul J.
- Venue
- Chemical Science
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2013
- Volume
- 4
- Issue
- 6
- Pages
- 2319
- ISSN
- 2041-6520 (ISSN-L)
- 2041-6539
- PMC
- PMC3784344
- OpenAlex
- W2110592482
- Cited by
- 398
- References
- 98
- Citations by year
- 2026: 16 · 2025: 42 · 2024: 29 · 2023: 32 · 2022: 41 · 2021: 24 · 2020: 42 · 2019: 43 · 2018: 32 · 2017: 28 · 2016: 40 · 2015: 17 · 2014: 10 · 2013: 2
- FWCI
- 8.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Chemical Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- U.S. Food and Drug Administration
- University of Illinois at Urbana-Champaign
- National Cancer Institute (F30CA168323)
- National Institute of General Medical Sciences (R01GM098453)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Keywords
- glycoconjugates, glucose conjugation, tumor targeting, Warburg effect, aerobic glycolysis, cytotoxin, cancer metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.